Technology | July 06, 2009

FDA Clears ATS Simulus Semirigid Annuloplasty Band

July 6, 2009 - ATS Medical Inc. today said the FDA cleared the first implant of the ATS Simulus Semirigid Annuloplasty Band, which was developed through the company’s collaboration with Genesee BioMedical and represents the latest addition to the expanding portfolio of valve repair products.

This product’s clinical applications expand the existing therapeutic options for surgeons and their patients. The Simulus Semirigid Band is designed to respect the natural motion of the mitral annulus during the cardiac cycle, allowing for a more physiologic valve repair. This unique characteristic can be particularly important in patients where both the aortic and mitral valves are being treated, the company said.

“This Simulus Semi-Rigid Band represents the next advancement in annuloplasty repair rings and provides an excellent option for my patients with mitral valve regurgitation,” said Robert F. Hebeler Jr., M.D., who performed the first implant of the product at Heart Hospital Baylor in Plano, Texas. “The band retains the natural saddle shape of the mitral valve annulus and preserves mobility during the cardiac phases, particularly in the aorto-mitral junction. These design characteristics make the Simulus Semirigid Band easy to implant.”

For more information: www.atsmedical.com

Related Content

News | Cardiovascular Surgery

August 15, 2022 — Unnatural, direct connections between arteries and veins, like an access point for kidney dialysis and ...

Home August 15, 2022
Home
News | Cardiovascular Surgery

August 12, 2022 — Atrium Health Pineville has earned a distinguished three-star rating – the highest possible ...

Home August 12, 2022
Home
Feature | Cardiovascular Surgery

The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 ...

Home June 14, 2022
Home
News | Cardiovascular Surgery

June 14, 2022 — The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI), a nonprofit organization ...

Home June 14, 2022
Home
News | Cardiovascular Surgery

April 29, 2022 – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking ...

Home April 29, 2022
Home
News | Cardiovascular Surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
News | Cardiovascular Surgery
February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA ...
Home February 15, 2022
Home
News | Cardiovascular Surgery

February 11, 2022 — Riverside Community Hospital has earned a distinguished three-star rating from The Society of ...

Home February 11, 2022
Home
News | Cardiovascular Surgery

November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...

Home November 23, 2021
Home
News | Cardiovascular Surgery

November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...

Home November 22, 2021
Home
Subscribe Now